These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24586244)

  • 21. Quantitative MRI analysis of cerebral lesions and atrophy in post-partum patients with multiple sclerosis.
    Khalid F; Healy BC; Dupuy SL; Chu R; Chitnis T; Bakshi R; Houtchens M
    J Neurol Sci; 2018 Sep; 392():94-99. PubMed ID: 30031994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential spinal cord volume loss in primary progressive multiple sclerosis.
    Tsagkas C; Magon S; Gaetano L; Pezold S; Naegelin Y; Amann M; Stippich C; Cattin P; Wuerfel J; Bieri O; Sprenger T; Kappos L; Parmar K
    Mult Scler; 2019 Jun; 25(7):947-957. PubMed ID: 29781383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study.
    Moodie J; Healy BC; Buckle GJ; Gauthier SA; Glanz BI; Arora A; Ceccarelli A; Tauhid S; Han XM; Venkataraman A; Chitnis T; Khoury SJ; Guttmann CR; Weiner HL; Neema M; Bakshi R
    J Neurol Sci; 2012 Apr; 315(1-2):49-54. PubMed ID: 22209496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.
    Giorgio A; Stromillo ML; Bartolozzi ML; Rossi F; Battaglini M; De Leucio A; Guidi L; Maritato P; Portaccio E; Sormani MP; Amato MP; De Stefano N
    Mult Scler; 2014 Feb; 20(2):214-9. PubMed ID: 23877971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferons-beta versus glatiramer acetate for relapsing-remitting multiple sclerosis.
    La Mantia L; Di Pietrantonj C; Rovaris M; Rigon G; Frau S; Berardo F; Gandini A; Longobardi A; Weinstock-Guttman B; Vaona A
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009333. PubMed ID: 25062935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of multiple sclerosis damage and repair: Linking cerebral hypoperfusion to the development of irreversible tissue loss in multiple sclerosis using magnetic resonance imaging.
    Mascali D; Villani A; Chiarelli AM; Biondetti E; Lipp I; Digiovanni A; Pozzilli V; Caporale AS; Rispoli MG; Ajdinaj P; D'Apolito M; Grasso E; Sensi SL; Murphy K; Tomassini V; Wise RG
    Eur J Neurol; 2023 Aug; 30(8):2348-2356. PubMed ID: 37154298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis.
    Giugni E; Pozzilli C; Bastianello S; Gasperini C; Paolillo A; Koudriavtseva T; Frontoni M; Farina D; Bozzao L
    Mult Scler; 1997 Aug; 3(4):221-5. PubMed ID: 9372503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
    Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
    Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis.
    Bonneville F; Moriarty DM; Li BS; Babb JS; Grossman RI; Gonen O
    AJNR Am J Neuroradiol; 2002 Mar; 23(3):371-5. PubMed ID: 11901002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
    Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
    Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H; Krakauer M; Skimminge A; Sellebjerg F; Garde E; Siebner HR; Paulson OB; Hesse D; Hanson LG
    PLoS One; 2013; 8(2):e56375. PubMed ID: 23441184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis.
    Brass SD; Benedict RH; Weinstock-Guttman B; Munschauer F; Bakshi R
    Mult Scler; 2006 Aug; 12(4):437-44. PubMed ID: 16900757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infratentorial hypointense lesion volume on T1-weighted magnetic resonance imaging correlates with disability in patients with chronic cerebellar ataxia due to multiple sclerosis.
    Hickman SJ; Brierley CM; Silver NC; Moseley IF; Scolding NJ; Compston DA; Miller DH
    J Neurol Sci; 2001 Jun; 187(1-2):35-9. PubMed ID: 11440742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
    Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
    Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.